chr6-116279230-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003309.4(TSPYL1):c.601G>A(p.Glu201Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000423 in 1,609,348 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003309.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSPYL1 | NM_003309.4 | c.601G>A | p.Glu201Lys | missense_variant | 1/1 | ENST00000368608.4 | NP_003300.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSPYL1 | ENST00000368608.4 | c.601G>A | p.Glu201Lys | missense_variant | 1/1 | NM_003309.4 | ENSP00000357597 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000309 AC: 47AN: 152128Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000610 AC: 15AN: 245788Hom.: 0 AF XY: 0.0000525 AC XY: 7AN XY: 133250
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1457220Hom.: 0 Cov.: 32 AF XY: 0.0000152 AC XY: 11AN XY: 725036
GnomAD4 genome AF: 0.000309 AC: 47AN: 152128Hom.: 0 Cov.: 32 AF XY: 0.000310 AC XY: 23AN XY: 74310
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2022 | The c.601G>A (p.E201K) alteration is located in exon 1 (coding exon 1) of the TSPYL1 gene. This alteration results from a G to A substitution at nucleotide position 601, causing the glutamic acid (E) at amino acid position 201 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at